RecruitingPhase 2 / Phase 3NCT06976268
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Sponsor: Biohaven Therapeutics Ltd.
Bellevue, WA · Seattle, WA · +22 more sites
1 recruiting parkinson's disease studies with a site in Bellevue, WA.
Sponsor: Biohaven Therapeutics Ltd.
Bellevue, WA · Seattle, WA · +22 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.